Comparison of ESC and ACCF/AHA Guidelines for Oral Antiplatelet Treatment in the Management of Patients with Acute Coronary Syndrome
Basically, acute coronary syndrome (ACS) is caused by the partial or total occlusion of coronary arteries because of platelet activation and aggregation. Hence, one of the major components of ACS treatment is the inhibition of platelet activation and aggregation. New studies performed in recent year...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2016-09-01
|
| Series: | Eurasian Journal of Emergency Medicine |
| Subjects: | |
| Online Access: |
http://akademikaciltip.com/archives/archive-detail/article-preview/comparison-of-esc-and-accf-aha-guidelines-for-oral/21815
|